It's official: Medicare covers Avonex. (news).Good news for anyone on Medicare who is considering or already taking Avonex: as of August 1, 2002, Medicare covers this FDA-approved MS disease-modifying drug because it is administered via intramuscular injection Noun 1. intramuscular injection - an injection into a muscle injection, shot - the act of putting a liquid into the body by means of a syringe; "the nurse gave him a flu shot" . However, Medicare will cover Avonex only when it is given "incidental Contingent upon or pertaining to something that is more important; that which is necessary, appertaining to, or depending upon another known as the principal. Under Workers' Compensation statutes, a risk is deemed incidental to employment when it is related to whatever a to a physician's services"--that is, in a doctor's office or hospital outpatient setting. Medicare will not cover Betaseron, Copaxone, and Rebif under any circumstances, because they are administered via subcutaneous injection Noun 1. subcutaneous injection - an injection under the skin injection, shot - the act of putting a liquid into the body by means of a syringe; "the nurse gave him a flu shot" . Because the decision regarding Avonex is new, you should contact your local Medicare program to make sure Avonex is included on its list of covered drugs, or formulary formulary /for·mu·lary/ (for´mu-lar?e) a collection of recipes, formulas, and prescriptions. National Formulary see under N. for·mu·lar·y n. . Local contact information can be found by calling 800-MEDICARE (800-633-4227) or by visiting www.medicare.gov/ coverage/home.asp and selecting your state and "prescription drugs prescription drug Prescription medication Pharmacology An FDA-approved drug which must, by federal law or regulation, be dispensed only pursuant to a prescription–eg, finished dose form and active ingredients subject to the provisos of the Federal Food, Drug, ". While we welcome this relief for Avonex users, the National MS Society believes it is unacceptable and inappropriate for Medicare to cover only one of the four FDA-approved disease-modifying injected drugs. The Society's national advocacy office is working with other concerned groups to make the case that Medicare must cover all four disease-modifying MS drugs. |
|
||||||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion